Faes Farma
Spanish pharmaceutical company
ISIN ES0134950F36 LEI 959800FXZQY7U3P1G969
Follow Faes Farma
Weekly email: filings, results
Revenue, last year
€610.5M
+23.7% vs prior year
Net income
€79.6M
−28.5% vs prior year
EPS, diluted
€0.25
−28.7% vs prior year
Operating cash flow
€78.5M
−32% vs prior year
Source: ESEF annual reports · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | €610.5M | €79.6M |
| FY24 | €493.6M | €111.4M |
| FY23 | €451.2M | €91.9M |
| FY22 | €438.8M | €89.6M |
| FY21 | €398.6M | €82.4M |
| FY20 | €380.2M | €72.5M |
| FY19 | €357.4M | €64M |
Show the numbers
| Year | Net margin |
|---|---|
| FY25 | 13% |
| FY24 | 22.6% |
| FY23 | 20.4% |
| FY22 | 20.4% |
| FY21 | 20.7% |
| FY20 | 19.1% |
| FY19 | 17.9% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | €62.4M |
| FY24 | €81.7M |
| FY23 | €5.2M |
| FY22 | €31.6M |
| FY21 | €28.2M |
| FY20 | €58.3M |
| FY19 | €50.6M |
- Dividends
- Buybacks
Show the numbers
| Year | Dividends | Buybacks |
|---|---|---|
| FY25 | €55.7M | - |
| FY24 | €48.2M | - |
| FY23 | €14.6M | - |
| FY22 | €18.1M | - |
| FY21 | €13.7M | - |
| FY20 | €12.2M | €92K |
| FY19 | €10.3M | €2.8M |
- Faes Farma
- Healthcare median
Show the numbers
| Year | Faes Farma | Healthcare median |
|---|---|---|
| FY25 | 13% | −30.6% |
| FY24 | 22.6% | −47% |
| FY23 | 20.4% | −58% |
| FY22 | 20.4% | −80.4% |
| FY21 | 20.7% | −71.9% |
| FY20 | 19.1% | −62.2% |
| FY19 | 17.9% | −46.3% |